You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股表現》美麗田園醫療健康(02373.HK)暗盤高開5.1%報20.3元
根據輝立交易平台顯示,下同一(16日)掛牌的美麗田園醫療健康(02373.HK)暗盤高開5.1%報20.3元,高低見28元/20元,現報26.05元,較上市價19.32元,高34.8%,成交61萬股。 公司是內地傳統美容及醫療美容服務商。是次來港上市以每股19.32元合共發售4,053.65萬股(包括1.614.1萬股舊股),並已引入包括TruMed、貝泰妮(300957.SZ)、巨子生物(02367.HK)控股股東Juzi Holding及Harvest四名基石投資者,合共認購2,169.7萬股;其中10%公開發售獲逾21倍超購,已啟動回撥機制佔比增至30%,認購一手中籤率55%;公司料集資淨額約3.87億元,主要用作擴張和升級服務網絡、進行戰略併購加盟店,以及進一步投資於信息技術系統等。上市聯席保薦人分別為大摩、海通國際及華泰國際。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account